HCR 576: Drug Development The process of bringing a new drug to the marketplace can be lengthy and complicated, sometimes exceeding a decade and requiring a commitment of great financial risk. As seen by Tamimi and Ellis, only one in a thousand of the synthesized compounds gets to clinical trials, with one out of every […]
HCR 578: Duty of Care The principal investigator (PI) has the obvious Duty of Care to the study participants, though this term is not specifically present in the informed consent form. Instead, this duty is implied through several elements of the document. First, the consent identifies that participants would be monitored through screening, follow-up visits, […]
HCR 578: Children in Research: Legal Protections and Special Considerations Introduction The safety and efficacy of medical products in children require pediatric research. In the past, children would not be included in clinical trials, and off-label use of drugs was common without understanding their effects, dosage, and effectiveness in children. New regulations are being put […]
HCR 576 Leadership Qualities Needed in the Food Industry Disruptions in the global food supply chains, changing consumer needs, food safety regulations, sustainability issues, and continuous innovation are some of the challenges that are encountered by the food industry. To cope with these complexities, leaders should possess qualities that can result in organizational success as […]
HCR 578 Ghostwriting in Scientific Authorship Introduction Ghostwriting in scientific and biomedical studies has become one of the most contentious processes in academic publishing. Ghostwriting is legally acceptable under the copyright’s work-for-hire doctrine. However, it is morally objectionable when it undermines scientific credibility, patient safety, and the integrity of academic research. The difference is two […]
HCR 576 Adverse Events & Post-Marketing Surveillance in Food Products If I were working in the Human Resources department of a food company and saw a YouTube video of a consumer reporting severe side effects from one of our combination food products, later ending in their death, I would have to respond immediately. It would […]
HCR 576: Food Recall The Recall of Deep-brand Frozen Vegetables & Fruit Products by Chetak LLC Group (2025) Introduction Food recalls are a critical component of public health protection, serving as interventions to prevent further harm from contaminated or defective products. Recalls normally occur in cases where a food item has been identified as […]
HCR 576 Pre-License Inspection & Pre-Approval Inspection Our group designed an extensive strategy of a Pre-License Inspection (PLI) and Pre-Approval Inspection (PAI), which are both carried out by the FDA prior to approval of a product or licensing of facilities. The inspections play an important role by ensuring the site is inspection-ready and adheres to […]
HCR 577 CTD Module 2 Table of Contents 2.2 Introduction to Summary—————————————————————-3 2.3 Quality Overall Summary—————————————————————3 2.4 Nonclinical Overview——————————————————————–4 2.5 Clinical Overview————————————————————————4 2.6 Nonclinical Written and Tabulated Summaries—————————————5 2.6.1 Introduction————————————————————————–5 2.6.2 Pharmacology Written Summary————————————————–5 2.6.3 Pharmacology Tabulated Summary————————————————-6 2.6.4 Pharmacokinetic Written Summary————————————————-6 2.6.5 Pharmacokinetic Tabulated Summary———————————————-7 2.6.6 Toxicology Written Summary——————————————————–8 2.6.7 Toxicology Tabulated Summary—————————————————–9 2.7 […]
HCR 577 Quality Testing of New Drugs When it comes to matters related to quality testing, it is essential for one to realize the fact that it is an important part of developing new drugs before they are legalized under the Investigational New Drug (IND) application or submitted as a final product (Lucideon Group, 2026). […]
